Armed Antibody Triggers Remissions For Hodgkin Lymphoma

Links shared publicly online about this topic.

751
total visits

Armed Antibody Triggers Remissions For Hodgkin Lymphoma

An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical tr

View full resource at medicalnewstoday.com

Tags: Cancer, Lymphoma, Hodgkin Lymphoma

Most Recently Shared on November 5, 2010 at 3:05 am By:

MNT Cancer News

Armed Antibody Triggers Remissions For Hodgkin Lymphoma http://mnt.to/3M5V #cancer

1 year ago...

Retweet

Favorite

Also Shared By:

MNT Leukemia

MNT Blood

Armed antibody triggers remissions for Hodgkin's lymphoma

sciencedaily.com — “An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, researchers report.” View full resource at sciencedaily.com

Most Recently Shared on November 5, 2010 at 2:08 am By:

sciencedaily Health News

Armed antibody triggers remissions for Hodgkin's lymphoma: An antibody loaded with an anti-cancer agent produced... http://bit.ly/c0QrPb

1 year ago...

Retweet

Favorite

Armed antibody triggers remissions for Hodgkin's lymphoma

physorg.com — “An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine.” View full resource at physorg.com